epirubicin has been researched along with Dendritic Cell Sarcoma, Interdigitating in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonanno, L; Conte, P; Dei Tos, AP; Di Liso, E; Ghiotto, C; Lodovichetti, G; Pennelli, N | 1 |
1 review(s) available for epirubicin and Dendritic Cell Sarcoma, Interdigitating
Article | Year |
---|---|
Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dendritic Cell Sarcoma, Interdigitating; Epirubicin; Humans; Ifosfamide; Indoles; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Proto-Oncogene Proteins B-raf; Sulfonamides; Vemurafenib | 2015 |